Jafar Ezzati Nazhad Dolatabadi | Nanotechnology | Best Researcher Award

Assoc. Prof. Dr. Jafar Ezzati Nazhad Dolatabadi, Tabriz University of Medical Sciences, Iran.

Dr. Jafar Ezzati Nazhad Dolatabadi is an Associate Professor at Tabriz University of Medical Sciences, specializing in pharmaceutical nanotechnology 🧪. With a strong background in biochemistry and molecular research, he has contributed extensively to nanomedicine, drug delivery systems, and cancer therapy 🎯. His research involves synthesizing and characterizing nanocarriers for drug delivery, cytotoxicity studies, and biophysical interactions. Dr. Dolatabadi has authored numerous publications in renowned journals 📖 and presented at international conferences 🌍. His ongoing research focuses on biosensors and molecular imprinting for medical and environmental applications.

Publication Profiles

Scopus

Education & Experience 🎓💼

✅ B.Sc. in Biology – Iran 🧬
✅ M.Sc. in Biochemistry – Razi University 🧪
✅ Ph.D. in Pharmaceutical Nanotechnology – Tabriz University of Medical Sciences 💊
✅ Associate Professor at Tabriz University of Medical Sciences since 2014 👨‍🏫
✅ Published extensively in international journals 📑
✅ Presented research at global conferences 🌎

Summary Suitability

Dr. Jafar Ezzati Nazhad Dolatabadi, an Associate Professor at Tabriz University of Medical Sciences, has made exceptional contributions to the field of Pharmaceutical Nanotechnology. With a robust academic foundation and extensive experience in researching drug delivery systems, nanomedicine, and anticancer therapies, Dr. Dolatabadi’s work stands out for its profound impact on improving therapeutic strategies. His innovative research in designing and characterizing novel drug formulations, along with his emphasis on nanocarriers for enhanced drug delivery, has earned him recognition and accolades in the scientific community. His dedication to advancing the field of pharmaceutical sciences makes him a deserving candidate for the Best Researcher Award.

Professional Development  📚🔍

Dr. Dolatabadi has significantly contributed to biomedical research with a focus on pharmaceutical nanotechnology 🧪, drug delivery 💊, and cancer therapy 🎗️. He has worked on nanolipidic carriers, biomolecular interactions, and cytotoxicity studies to improve targeted drug formulations. His expertise extends to surface plasmon resonance, spectroscopy, and molecular imprinting for biosensing applications 🔍. With over 20 research projects completed, his innovations aid in drug safety, targeted therapies, and environmental health monitoring 🌱. His current research integrates nanotechnology with electrochemical biosensors, enhancing medical diagnostics and food safety testing 🏥.

Research Focus

Dr. Jafar Ezzati Nazhad Dolatabadi’s research focuses on pharmaceutical nanotechnology 🧪, with an emphasis on drug delivery systems 💊, cancer therapies 🎗️, and biomolecular interactions 🔬. His work involves developing nanolipidic carriers, dendrimers, and polymeric systems to improve drug bioavailability and targeting. He explores cytotoxicity and genotoxicity studies 🧬 to assess the safety of pharmaceuticals and food additives 🍽️. Additionally, he is working on biosensors for detecting contaminants in food and the environment 🌱, using techniques like surface plasmon resonance for real-time molecular interaction analysis. His research bridges medicine, biotechnology, and environmental science 🌍.

Awards & Honors 🏆🎖

🏅 International Research Awards in Pharmaceutical Nanotechnology 🧪
🏅 Best Research Paper Awards in Nanomedicine & Biophysics 📜
🏅 Recognized at International Conferences for Biochemical Research 🌎
🏅 Recipient of Prestigious Grants for Drug Delivery Innovations 💰
🏅 Academic Excellence Award for Contributions to Biomedical Science 🏆

Publications Top Noted

  • “Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer.” Scientific Reports 🌐.
  • “Functionalizing of magnetic nanoparticles as nano-architecture towards bioimaging and colorimetric recognition of MCF-7 cells: dual opto-sensing and fluorescence monitoring for early-stage diagnosis of breast cancer.” Mikrochimica Acta 🧪.
  • “PAMAM dendrimers based co-delivery of methotrexate and berberine for targeting of Hela cancer cells.” Toxicology Reports ⚗️. 1 citation.
  • “Applications of Advanced Nanomaterials in Biomedicine, Pharmaceuticals, Agriculture, and Food Industry.” BioNanoScience 🧬. 5 citations.
  • “Probing amikacin interaction with albumin: A combined multispectral and molecular docking investigation.” Heliyon 🧫. 0 citations.
  • “Cytotoxic and genotoxic effects of tert-butylhydroquinone, butylated hydroxyanisole and propyl gallate as synthetic food antioxidants.” Food Science and Nutrition 🍏. 4 citations.
  • “Polysaccharide-based sensors and nanosensors: A review of recent progress and challenges.” Microchemical Journal 🧪. 2 citations.
  • “Probing binding mode between sodium acid pyrophosphate and albumin: multi-spectroscopic and molecular docking analysis.” Journal of Biomolecular Structure and Dynamics 🧬. 2 citations.
Jafar Ezzati Nazhad Dolatabadi | Nanotechnology | Best Researcher Award

You May Also Like